Keywords: تالیدومید; Thalidomide; Thermal stability; Polymorphs; Gamma irradiation; Hirshfeld;
مقالات ISI تالیدومید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تالیدومید; Thalidomide; Lifelong disability; Health; Aging;
Keywords: تالیدومید; Multiple myeloma; Toxic death; Early mortality; Newly diagnosed; Transplant-Ineligible; New drugs; Bortezomib; Lenalidomide; Thalidomide;
Keywords: تالیدومید; PTCA; Percutaneous transluminal coronary angioplasty; VEGF; Vascular endothelial growth factor; TNF-α; Tumor necrosis factor-α; ELISA; Enzyme-linked immunosorbent assay; RT-PCR; Real-time reverse transcriptase polymerase chain reaction; DES; Drug-elutin
Keywords: تالیدومید; Thalidomide; Gastrointestinal haemorrhage; Ventricular assist devices;
Keywords: تالیدومید; POCD; postoperative cognitive dysfunction; RGS; grimace scale; POD; postoperative day; NMDA; N-methyl-D-aspartate; TNF-α; tumor necrosis factor-α; IL; interleukin; postoperative cognitive dysfunction (POCD); thalidomide; pain; NMDA receptors; inflammati
Keywords: تالیدومید; Angiodysplasia; Endoscopy; Thalidomide; Octreotide; Argon Plasma Coagulation;
Keywords: تالیدومید; Statistical evidence; Evidence of mechanism; Russo-Williamson thesis; Evidence-based medicine; Streptomycin; Thalidomide;
Keywords: تالیدومید; Hydroxyurea; JAK2 inhibitor; Myeloproliferative neoplasm; Thalidomide; Treatment;
Keywords: تالیدومید; Neuropathy; Stem cells; IPSC-derived neurons; Taxanes; Platinating agents; Bortezomib; Thalidomide; Goshajinkigan;
Keywords: تالیدومید; Thalidomide; VEGF; NF-kappa B; TNF-α; bFGF; Angiopoietin-2;
Keywords: تالیدومید; Thalidomide; Embryopathy; Teratogenesis; Pharmacovigilance;
Keywords: تالیدومید; Thalidomide; Lenalidomide; Myeloma; Comparative effectiveness; Peripheral neuropathy; Survival;
Keywords: تالیدومید; Angiogenesis; Chicken; Zebrafish; Mouse; Rat; Rabbit; Non-human primates; Thalidomide;
Keywords: تالیدومید; Crohn disease; thalidomide; sensorimotor polyneuropathy; CMAP; Compound motor action potential; EMG; Electromyography; SNAP; Sensory nerve action potential;
Keywords: تالیدومید; actinic prurigo; itch; prurigo nodularis; pruritus; thalidomide; FDA; Food and Drug Administration; NCS; nerve conduction studies; REMS; Risk Evaluation and Mitigation Strategy;
Keywords: تالیدومید; Bevacizumab; Maintenance; SCLC; Target therapy; Thalidomide;
Keywords: تالیدومید; Thalidomide; Diabetic neuropathy; Rostral ventromedial medulla; Zucker diabetic fatty rats; Pain;
Keywords: تالیدومید; Angiogenesis; Cancer; EM-12; Multiple myeloma; Teratogenesis; Thalidomide; TNF-α;
Keywords: تالیدومید; Targeted drug delivery systems; Animal model of EPR effect; Tumor vessel permeability; Thalidomide; Antitumor efficacy; Distribution;
Keywords: تالیدومید; Liver cancer; Progenitor cells; Thalidomide; Analogues; Lenalidomide; Sorafenib; Apoptosis; Mitosis; LPCs; liver progenitor cells; HCC; hepatocellular carcinoma; FDA; Federal Drug Administration; SAR; structure activity relationship; BMOL; bipotential mou
Keywords: تالیدومید; Thalidomide; Teratogenicity; Eye development; Chick embryo; Nitric oxide; Transcriptome; DAR-4M-AM; 3â²,6â²-Bis(dimethylamino)-9-[2-acetomethoxycarbonyl-3-amino-4-(N-methylamino) phenyl]xanthylium iodide; DAF-FM; 4-Amino-5-Methylamino-2â²,7â²-Difluoro
Keywords: تالیدومید; Crohn's disease; Melkersson-Rosenthal syndrome; Orofacial granulomatosis; Thalidomide;
Keywords: تالیدومید; Thalidomide; Transcriptomics; Embryonic stem cell; Developmental toxicity; Differentiation; Microarray; Mouse
Keywords: تالیدومید; szpiczak plazmocytowy; niewydolność nerek; talidomid; lenalidomid; bortezomib; karfilzomibMultiple myeloma; Renal insufficiency; Thalidomide; Lenalidomide; Bortesomib; Carfilzomib
Keywords: تالیدومید; Thal; Thalidomide; VTE; venous thrombosis; Dex; dexamethasone; vWF; von Willebrand factor; ECs; endothelial cells; IL-6; interleukin-6; TNFα; tumor necrosis factor; HUVECs; human umbilical vein endothelial cells; DMSO; dimethyl sulfoxide; FITC; Fluoresce
Keywords: تالیدومید; Streptozotocin; Rat dementia model; Thalidomide; Etanercept; InfliximabaCSF, artificial cerebrospinal fluid; AD, Alzheimer's disease; Aβ, amyloid beta; BBB, blood–brain barrier; CNS, central nervous system; DAB, diaminobenzidine; H&E, hematoxylin and eosi
Keywords: تالیدومید; Gastric mucosal damage; Ethanol; Thalidomide; Inflammation; Nitric oxide;
Keywords: تالیدومید; Thalidomide; Inflammation; Oxidative stress; Apoptosis; Stroke; Neuro-protection
Keywords: تالیدومید; Thalidomide; Molecular probes; Triazole; Click reaction; Fluorescence;
Keywords: تالیدومید; Metabolic pathway of drug; Molecular chirality; Thalidomide; Chemical reaction network;
Keywords: تالیدومید; Leprosy; M. leprae; Anti-inflammatory; Analgesic; TNFα; Dapsone; Thalidomide; Molecular hybridization; Erythema nodosum leprosum;
Keywords: تالیدومید; Complete remission; Hepatocellular carcinoma; Thalidomide
Keywords: تالیدومید; B-cell clonality; EBV; High-dose mephalan; Secondary primary malignancy; Thalidomide;
Keywords: تالیدومید; Thalidomide; Seizure; l-Arginine-nitric oxide pathway; Aminoguanidine; Neuronal NOS; Mice;
Keywords: تالیدومید; Multiple myeloma; Thalidomide; Transplantation, autologous; Cyclophosphamide; Induction chemotherapy
Keywords: تالیدومید; Anorexia; Cachexia; Pancreatic adenocarcinoma; Megestrol; Thalidomide; Corticosteroids
Keywords: تالیدومید; Phthalimide analogs; 2-Phthalimidethanol; 2-Phthalimidethyl nitrate; Thalidomide; Inflammation; Pain;
Keywords: تالیدومید; Intravaginal administration; Thalidomide; Rabbits; Toxicokinetics; Seminal transfer; Embryo-fetal development;
Keywords: تالیدومید; Placenta; Maternal imagination; Pregnancy; Teratology; Thalidomide; Anatomical barriers;
Keywords: تالیدومید; Thalidomide; NOS3; eNOS; Teratogenesis; Thalidomide embryophathy;
Keywords: تالیدومید; Thalidomide; Anti-angiogenesis; Phthalimide;
Keywords: تالیدومید; Thalidomide; Paraquat; Lung injury; Cytokines; Nitric oxide;
Keywords: تالیدومید; Myelodysplastic syndrome (MDS); Systematic review; Clinical trials; Immunomodulatory agents; Lenalidomide; Thalidomide;
Keywords: تالیدومید; analgesia; morphine tolerance; thalidomide
Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
Keywords: تالیدومید; HDAC; Degrader; PROTAC; Cereblon; Thalidomide; Epigenetic;
Use of erlotinib and thalidomide in advanced NSCLC patients with acquired resistance to erlotinib: A pilot study
Keywords: تالیدومید; Non-small-cell lung cancer; Thalidomide; EGFR-TKI; Acquired resistance; Erlotinib;
Neuro- and nephroprotective effect of grape seed proanthocyanidin extract against carboplatin and thalidomide through modulation of inflammation, tumor suppressor protein p53, neurotransmitters, oxidative stress and histology
Keywords: تالیدومید; Thalidomide; Carboplatin; Grape seed proanthocyanidin extract; Neurotoxicity; Nephrotoxicity;
POEMS Syndrome
Keywords: تالیدومید; POEMS syndrome; Autologous stem cell transplantation; VEGF; Lenalidomide; Thalidomide; Bortezomib;
Pharmacological treatment of gastrointestinal bleeding due to angiodysplasias: A position paper of the Italian Society of Gastroenterology (SIGE)
Keywords: تالیدومید; Angiodysplasia; Gastrointestinal bleeding; Hormonal therapy; Somatostatin analogues; Thalidomide;